학술논문

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Document Type
Article
Source
In Annals of Oncology April 2016 27(4):619-624
Subject
Language
ISSN
0923-7534